XML 50 R39.htm IDEA: XBRL DOCUMENT v3.25.1
Derivatives (Tables)
3 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Primary Risks Managed by Derivatives
The following table presents the primary underlying risk exposure, gross notional amount and estimated fair value of the Company’s derivatives, excluding embedded derivatives, held at:
March 31, 2025December 31, 2024
Primary Underlying Risk ExposureGross
Notional
Amount
Estimated Fair ValueGross
Notional
Amount
Estimated Fair Value
AssetsLiabilitiesAssetsLiabilities
(In millions)
Derivatives Designated as Hedging Instruments:
Fair value hedges:
Interest rate swapsInterest rate$5,108 $990 $636 $5,188 $1,018 $666 
Foreign currency swapsForeign currency exchange rate1,454 23 31 1,454 33 67 
Foreign currency forwardsForeign currency exchange rate150 — 38 150 — 41 
Subtotal6,712 1,013 705 6,792 1,051 774 
Cash flow hedges:
Interest rate swapsInterest rate4,135 13 321 4,154 — 359 
Interest rate forwardsInterest rate5,474 85 908 4,901 56 880 
Foreign currency swapsForeign currency exchange rate47,175 2,913 1,742 45,879 2,858 1,877 
Subtotal56,784 3,011 2,971 54,934 2,914 3,116 
Net investment in a foreign operation (“NIFO”) hedges:
Foreign currency forwardsForeign currency exchange rate1,086 11 1,553 42 — 
Currency optionsForeign currency exchange rate3,000 522 — 3,000 536 — 
Subtotal4,086 526 11 4,553 578 — 
Total qualifying hedges67,582 4,550 3,687 66,279 4,543 3,890 
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate swapsInterest rate30,504 1,575 1,326 29,238 1,414 1,263 
Interest rate floorsInterest rate6,040 71 — 6,169 38 — 
Interest rate capsInterest rate16,648 86 — 17,998 133 
Interest rate futuresInterest rate2,229 12 1,667 
Interest rate optionsInterest rate34,581 181 137 34,939 210 217 
Interest rate forwardsInterest rate3,261 202 76 3,128 135 77 
Synthetic GICsInterest rate53,796 — — 49,599 — — 
Foreign currency swapsForeign currency exchange rate10,684 1,096 185 10,708 1,192 190 
Foreign currency forwardsForeign currency exchange rate16,192 174 1,051 13,471 47 1,277 
Currency futuresForeign currency exchange rate308 — 301 — 
Credit default swaps — purchasedCredit2,771 68 2,791 14 67 
Credit default swaps — writtenCredit12,096 204 11,764 201 
Equity futuresEquity market1,811 37 1,840 
Equity index optionsEquity market13,991 306 232 12,743 233 253 
Equity variance swapsEquity market114 — 114 — 
Equity total return swapsEquity market1,799 107 20 1,799 41 
Longevity swaps
Longevity1,000 — — 1,000 — — 
Total non-designated or nonqualifying derivatives207,825 4,052 3,115 199,269 3,669 3,369 
Total$275,407 $8,602 $6,802 $265,548 $8,212 $7,259 
Included in the table above, the Company uses various over-the-counter (“OTC”) and exchange traded derivatives to hedge variable annuity guarantees. The table below presents the gross notional amount, estimated fair value and primary underlying risk exposure of the derivatives hedging variable annuity guarantees accounted for as MRBs:
March 31, 2025December 31, 2024
Primary Underlying Risk ExposureGross
Notional
Amount
Estimated Fair ValueGross
Notional
Amount
Estimated Fair Value
AssetsLiabilitiesAssetsLiabilities
(In millions)
Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate$8,964 $14 $727 $8,913 $11 $768 
Foreign currency exchange rate409 378 — 
Equity market4,222 167 120 4,294 132 113 
$13,595 $187 $848 $13,585 $143 $883 
The Effects of Derivatives on the Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
The following table presents the interim condensed consolidated financial statement location and amount of gain (loss) recognized on fair value, cash flow, NIFO, nonqualifying hedging relationships and embedded derivatives:
Three Months Ended March 31, 2025
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$(1)$— N/A$75 $42 $— N/A
Hedged items
— N/A(79)(40)— N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
(10)N/A— 36 — N/A
Hedged items
10 (6)N/A— (36)— N/A
Amount excluded from the assessment of hedge effectiveness
— (3)N/A— — — N/A
Subtotal
— (1)N/A(4)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$113 
Amount of gains (losses) reclassified from AOCI into income
17 — — — — — (17)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A121 
Amount of gains (losses) reclassified from AOCI into income
360 — — — — (362)
Foreign currency transaction gains (losses) on hedged items
— (358)— — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A— 
Subtotal
19 — — — — (145)
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A(72)
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A(14)
Subtotal
N/A— N/AN/AN/AN/A(86)
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A98 N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A245 N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/A(9)N/AN/AN/AN/A
Credit derivatives — written (1)
— N/A(27)N/AN/AN/AN/A
Equity derivatives (1)
17 N/A59 N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A(31)N/AN/AN/AN/A
Subtotal
17 N/A335 N/AN/AN/AN/A
Earned income on derivatives
95 — 110 (40)— — 
Synthetic GICsN/AN/A19 N/AN/AN/AN/A
Embedded derivatives - ceded reinsurance
N/AN/A(35)N/AN/AN/AN/A
Embedded derivatives - other
N/AN/AN/AN/AN/AN/A
Total
$131 $$432 $(2)$(38)$— $(231)
Three Months Ended March 31, 2024
Net
Investment
Income
Net
Investment
Gains
(Losses)
Net
Derivative
Gains
(Losses)
Policyholder
Benefits and
Claims
Interest
Credited to
PABs
Other
Expenses
OCI
(In millions)
Gain (Loss) on Fair Value Hedges:
Interest rate derivatives:
Derivatives designated as hedging instruments (1)
$— $— N/A$(109)$(43)$— N/A
Hedged items
— — N/A103 42 — N/A
Foreign currency exchange rate derivatives:
Derivatives designated as hedging instruments (1)
(31)N/A— (24)— N/A
Hedged items
(2)23 N/A— 28 — N/A
Amount excluded from the assessment of hedge effectiveness
— N/A— — — N/A
Subtotal
(4)N/A(6)— N/A
Gain (Loss) on Cash Flow Hedges:
Interest rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A$(218)
Amount of gains (losses) reclassified from AOCI into income
— — — — (10)
Foreign currency exchange rate derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A(123)
Amount of gains (losses) reclassified from AOCI into income
(368)— — — — 367 
Foreign currency transaction gains (losses) on hedged items
— 351 — — — — — 
Credit derivatives: (1)
Amount of gains (losses) deferred in AOCI
N/AN/AN/AN/AN/AN/A— 
Subtotal
(15)— — — — 16 
Gain (Loss) on NIFO Hedges:
Foreign currency exchange rate derivatives (1)N/A— N/AN/AN/AN/A160 
Non-derivative hedging instrumentsN/AN/AN/AN/AN/AN/A20 
Subtotal
N/A— N/AN/AN/AN/A180 
Gain (Loss) on Derivatives Not Designated or Not Qualifying as Hedging Instruments:
Interest rate derivatives (1)
— N/A(353)N/AN/AN/AN/A
Foreign currency exchange rate derivatives (1)
— N/A(706)N/AN/AN/AN/A
Credit derivatives — purchased (1)
— N/A(7)N/AN/AN/AN/A
Credit derivatives — written (1)
— N/A34 N/AN/AN/AN/A
Equity derivatives (1)
(25)N/A(342)N/AN/AN/AN/A
Foreign currency transaction gains (losses) on hedged items
— N/A163 N/AN/AN/AN/A
Subtotal
(25)N/A(1,211)N/AN/AN/AN/A
Earned income on derivatives
30 — 181 (4)(49)— — 
Synthetic GICsN/AN/A19 N/AN/AN/AN/A
Embedded derivativesN/AN/A32 N/AN/AN/AN/A
Total
$16 $(19)$(979)$(10)$(46)$— $196 
__________________
(1)Excludes earned income on derivatives.
Fair Value Hedges
The following table presents the balance sheet classification, carrying amount and cumulative fair value hedging adjustments for items designated and qualifying as hedged items in fair value hedges:
Balance Sheet Line ItemCarrying Amount
 of the Hedged
Assets/(Liabilities)
Cumulative Amount
of Fair Value Hedging Adjustments
Included in the Carrying Amount of Hedged
Assets/(Liabilities) (1)
March 31, 2025December 31, 2024March 31, 2025December 31, 2024
(In millions)
Fixed maturity securities AFS$230 $241 $— $— 
Mortgage loans$163 $130 $— $(1)
FPBs
$(2,563)$(2,583)$285 $359 
PABs
$(2,386)$(2,170)$45 $223 
__________________
(1)Includes ($90) million and ($91) million of hedging adjustments on discontinued hedging relationships at March 31, 2025 and December 31, 2024, respectively.
Schedule of estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps
The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of written credit default swaps at:
March 31, 2025December 31, 2024
Rating Agency Designation of Referenced
Credit Obligations (1)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
Estimated
Fair Value
of Credit
Default
Swaps
Maximum
Amount of Future
Payments under
Credit Default
Swaps
Weighted
Average
Years to
Maturity (2)
(Dollars in millions)
Aaa/Aa/A
Single name credit default swaps (3)
$$96 1.7$$72 1.9
Credit default swaps referencing indices
65 4,126 2.072 4,126 2.2
Subtotal
66 4,222 2.073 4,198 2.2
Baa
Single name credit default swaps (3)
71 1.2102 1.6
Credit default swaps referencing indices
118 7,436 5.2111 7,263 4.1
Subtotal
119 7,507 5.2112 7,365 4.1
Ba
Single name credit default swaps (3)
— — 0.0— 17 1.1
Credit default swaps referencing indices
25 1.725 2.0
Subtotal
25 1.742 1.6
B
Single name credit default swaps (3)
— 23 1.0— — 0.0
Credit default swaps referencing indices
16 304 4.410 144 3.7
Subtotal
16 327 4.110 144 3.7
Caa
Credit default swaps referencing indices
(1)15 1.7(1)15 2.0
Subtotal
(1)15 1.7(1)15 2.0
Total
$201 $12,096 4.0$196 $11,764 3.4
_________________
(1)The rating agency designations are based on availability and the midpoint of the applicable ratings among Moody’s Investors Service, Inc. (“Moody’s”), Standard & Poor’s Global Ratings (“S&P”) and Fitch Ratings Inc. If no rating is available from a rating agency, then an internally developed rating is used.
(2)The weighted average years to maturity of the credit default swaps is calculated based on weighted average gross notional amounts.
(3)Single name credit default swaps may be referenced to the credit of corporations, foreign governments, or municipals.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
March 31, 2025December 31, 2024
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$8,527 $6,425 $8,224 $6,966 
OTC-cleared (1)
181 406 135 299 
Exchange-traded
42 14 11 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
8,750 6,845 8,370 7,272 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,280)(3,280)(3,633)(3,633)
OTC-cleared
(18)(18)(5)(5)
Exchange-traded
(10)(10)(1)(1)
Cash collateral: (3), (4)
OTC-bilateral
(2,522)— (2,597)— 
OTC-cleared
(141)(380)(126)(289)
Exchange-traded
— (3)— (6)
Securities collateral: (5)
OTC-bilateral
(2,554)(3,139)(1,955)(3,325)
OTC-cleared
— (8)— (4)
Exchange-traded
— (1)— — 
Net amount after application of master netting agreements and collateral
$225 $$53 $
__________________
(1)At March 31, 2025 and December 31, 2024, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $148 million and $158 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of $43 million and $13 million, respectively.
(2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2025 and December 31, 2024, the Company received excess cash collateral of $45 million and $26 million, respectively, and provided excess cash collateral of $86 million at both periods, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at March 31, 2025, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At March 31, 2025 and December 31, 2024, the Company received excess securities collateral with an estimated fair value of $357 million and $410 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At March 31, 2025 and December 31, 2024, the Company provided excess securities collateral with an estimated fair value of $1.4 billion and $1.2 billion, respectively, for its OTC-bilateral derivatives, $806 million and $835 million, respectively, for its OTC-cleared derivatives, and $188 million and $148 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of Derivative Assets and Liabilities after Master Netting Agreements and Cash Collateral
The estimated fair values of the Company’s net derivative assets and net derivative liabilities after the application of master netting agreements and collateral were as follows at:
March 31, 2025December 31, 2024
Derivatives Subject to a Master Netting Arrangement or a Similar Arrangement AssetsLiabilitiesAssetsLiabilities
(In millions)
Gross estimated fair value of derivatives:
OTC-bilateral (1)
$8,527 $6,425 $8,224 $6,966 
OTC-cleared (1)
181 406 135 299 
Exchange-traded
42 14 11 
Total gross estimated fair value of derivatives presented on the interim condensed consolidated balance sheets (1)
8,750 6,845 8,370 7,272 
Gross amounts not offset on the interim condensed consolidated balance sheets:
Gross estimated fair value of derivatives: (2)
OTC-bilateral
(3,280)(3,280)(3,633)(3,633)
OTC-cleared
(18)(18)(5)(5)
Exchange-traded
(10)(10)(1)(1)
Cash collateral: (3), (4)
OTC-bilateral
(2,522)— (2,597)— 
OTC-cleared
(141)(380)(126)(289)
Exchange-traded
— (3)— (6)
Securities collateral: (5)
OTC-bilateral
(2,554)(3,139)(1,955)(3,325)
OTC-cleared
— (8)— (4)
Exchange-traded
— (1)— — 
Net amount after application of master netting agreements and collateral
$225 $$53 $
__________________
(1)At March 31, 2025 and December 31, 2024, derivative assets included income (expense) accruals reported in accrued investment income or in other liabilities of $148 million and $158 million, respectively, and derivative liabilities included (income) expense accruals reported in accrued investment income or in other liabilities of $43 million and $13 million, respectively.
(2)Estimated fair value of derivatives is limited to the amount that is subject to set-off and includes income or expense accruals.
(3)Cash collateral received by the Company for OTC-bilateral and OTC-cleared derivatives, where the central clearinghouse treats variation margin as collateral, is included in cash and cash equivalents, short-term investments or in fixed maturity securities AFS, and the obligation to return it is included in payables for collateral under securities loaned and other transactions on the balance sheet. For certain collateral agreements, cash collateral is pledged to the Company as initial margin on its OTC-bilateral derivatives.
(4)The receivable for the return of cash collateral provided by the Company is inclusive of initial margin on exchange-traded and OTC-cleared derivatives and is included in premiums, reinsurance and other receivables on the balance sheet. The amount of cash collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements. At March 31, 2025 and December 31, 2024, the Company received excess cash collateral of $45 million and $26 million, respectively, and provided excess cash collateral of $86 million at both periods, which is not included in the table above due to the foregoing limitation.
(5)Securities collateral received by the Company is held in separate custodial accounts and is not recorded on the balance sheet. Subject to certain constraints, the Company is permitted by contract to sell or re-pledge this collateral, but at March 31, 2025, none of the collateral had been sold or re-pledged. Securities collateral pledged by the Company is reported in fixed maturity securities AFS on the balance sheet. Subject to certain constraints, the counterparties are permitted by contract to sell or re-pledge this collateral. The amount of securities collateral offset in the table above is limited to the net estimated fair value of derivatives after application of netting agreements and cash collateral. At March 31, 2025 and December 31, 2024, the Company received excess securities collateral with an estimated fair value of $357 million and $410 million, respectively, for its OTC-bilateral derivatives, which are not included in the table above due to the foregoing limitation. At March 31, 2025 and December 31, 2024, the Company provided excess securities collateral with an estimated fair value of $1.4 billion and $1.2 billion, respectively, for its OTC-bilateral derivatives, $806 million and $835 million, respectively, for its OTC-cleared derivatives, and $188 million and $148 million, respectively, for its exchange-traded derivatives, which are not included in the table above due to the foregoing limitation.
Estimated Fair Value of OTC-bilateral derivatives after considering effect of netting agreements
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
March 31, 2025December 31, 2024
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position (1)$3,078 $67 $3,145 $3,213 $120 $3,333 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$3,797 $76 $3,873 $3,829 $124 $3,953 
__________________
(1)After taking into consideration the existence of netting agreements.
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationMarch 31, 2025December 31, 2024
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld on ceded reinsurance
Other liabilities$(127)$(163)
Fixed annuities with equity indexed returns
PABs
170 172 
Total
$43 $
Embedded Derivatives
The following table presents the estimated fair value of the Company’s OTC-bilateral derivatives that were in a net liability position after considering the effect of netting agreements, together with the estimated fair value and balance sheet location of the collateral pledged.
March 31, 2025December 31, 2024
Derivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
TotalDerivatives
Subject to
Credit-
Contingent
Provisions
Derivatives
Not Subject
to Credit-
Contingent
Provisions
Total
(In millions)
Estimated fair value of derivatives in a net liability position (1)$3,078 $67 $3,145 $3,213 $120 $3,333 
Estimated fair value of collateral provided:
Fixed maturity securities AFS
$3,797 $76 $3,873 $3,829 $124 $3,953 
__________________
(1)After taking into consideration the existence of netting agreements.
The following table presents the estimated fair value and balance sheet location of the Company’s embedded derivatives that have been separated from their host contracts at:
Balance Sheet LocationMarch 31, 2025December 31, 2024
(In millions)
Embedded derivatives within liability host contracts:
Funds withheld on ceded reinsurance
Other liabilities$(127)$(163)
Fixed annuities with equity indexed returns
PABs
170 172 
Total
$43 $